Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry

Study Identifier:
M07-001
ClinicalTrials.gov Identifier:
NCT01374360
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete

Study Details

Medical Condition
  • Unmapped
Study Drug
    Date
    Oct 2004 - Aug 2024
    Phase 1
    Phase 2
    Phase 3
    Phase 4
    N/A
    Patient Requirements
    Sex: Female & Male
    Age: N/A - N/A
    Requirements Information
    Sex
    Female & Male
    Age
    N/A - N/A

    Study Details

    Medical Condition
    • Unmapped
    Study Drug
      Date
      Oct 2004 - Aug 2024
      Phase 1
      Phase 2
      Phase 3
      Phase 4
      N/A
      Patient Requirements
      Sex: Female & Male
      Age: N/A - N/A years
      Requirements Information

      Protocol Summary

      This study is a collection of data to evaluate safety and characterize progression of Paroxysmal Nocturnal Hemoglobinuria (PNH).

      Trial Locations

      Location
      Status
      Location
      Contact the PNH Registry at Alexion Pharmaceuticals, Inc. for worldwide locations.
      Boston, Massachusetts, United States, 02210
      Status
      N/A